Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 109 entries
Sorted by: Best Match Show Resources per page
Emergence of new insect-restrictive viruses in the Amazon region.

Genome announcements

Nunes MR, Silva SP, Carvalho VL, Vasconcelos JM, Da Silva DE, Oliveira LF, Nunes Neto JP, Rodrigues SG, Azevedo RS, Monteiro HA, Cardoso JF, Guzman H, Tesh R, Vasconcelos PF, Vianez-Júnior JL, Martins LC.
PMID: 25792052
Genome Announc. 2015 Mar 19;3(2). doi: 10.1128/genomeA.00131-15.

The complete genome was determined for 12 viruses isolated from 8 different pools of mosquitoes (Culex sp. and Psorophora ferox) collected at Brejeira farm, Canaan dos Carajas, Para state in northern Brazil. Eight of the viruses were distantly related...

Cite
Nunes MR, Silva SP, Carvalho VL, et al. Emergence of new insect-restrictive viruses in the Amazon region. Genome Announc. 2015;3(2)doi: 10.1128/genomeA.00131-15.
Nunes, M. R., Silva, S. P., Carvalho, V. L., Vasconcelos, J. M., Da Silva, D. E., Oliveira, L. F., Nunes Neto, J. P., Rodrigues, S. G., Azevedo, R. S., Monteiro, H. A., Cardoso, J. F., Guzman, H., Tesh, R., Vasconcelos, P. F., Vianez-Júnior, J. L., & Martins, L. C. (2015). Emergence of new insect-restrictive viruses in the Amazon region. Genome announcements, 3(2), . https://doi.org/10.1128/genomeA.00131-15
Nunes, Márcio R T, et al. "Emergence of new insect-restrictive viruses in the Amazon region." Genome announcements vol. 3,2 (2015). doi: https://doi.org/10.1128/genomeA.00131-15
Nunes MR, Silva SP, Carvalho VL, Vasconcelos JM, Da Silva DE, Oliveira LF, Nunes Neto JP, Rodrigues SG, Azevedo RS, Monteiro HA, Cardoso JF, Guzman H, Tesh R, Vasconcelos PF, Vianez-Júnior JL, Martins LC. Emergence of new insect-restrictive viruses in the Amazon region. Genome Announc. 2015 Mar 19;3(2). doi: 10.1128/genomeA.00131-15. PMID: 25792052; PMCID: PMC4395057.
Copy Download .nbib Format: NLM
Profile of panobinostat and its potential for treatment in solid tumors: an update.

OncoTargets and therapy

Anne M, Sammartino D, Barginear MF, Budman D.
PMID: 24265556
Onco Targets Ther. 2013 Nov 15;6:1613-24. doi: 10.2147/OTT.S30773. eCollection 2013.

The histone deacetylase (HDAC) inhibitors have emerged as novel therapies for cancer. Panobinostat (LBH 589, Novartis Pharmaceuticals) is a pan-deacetylase inhibitor that is being evaluated in both intravenous and oral formulations across multiple tumor types. Comparable to the other...

Cite
Anne M, Sammartino D, Barginear MF, et al. Profile of panobinostat and its potential for treatment in solid tumors: an update. Onco Targets Ther. 2013;6:1613-24doi: 10.2147/OTT.S30773.
Anne, M., Sammartino, D., Barginear, M. F., & Budman, D. (2013). Profile of panobinostat and its potential for treatment in solid tumors: an update. OncoTargets and therapy, 61613-24. https://doi.org/10.2147/OTT.S30773
Anne, Madhurima, et al. "Profile of panobinostat and its potential for treatment in solid tumors: an update." OncoTargets and therapy vol. 6 (2013): 1613-24. doi: https://doi.org/10.2147/OTT.S30773
Anne M, Sammartino D, Barginear MF, Budman D. Profile of panobinostat and its potential for treatment in solid tumors: an update. Onco Targets Ther. 2013 Nov 15;6:1613-24. doi: 10.2147/OTT.S30773. eCollection 2013. PMID: 24265556; PMCID: PMC3833618.
Copy Download .nbib Format: NLM
Improved Statistical Methods are Needed to Advance Personalized Medicine.

The open translational medicine journal

Alemi F, Erdman H, Griva I, Evans CH.
PMID: 20676226
Open Transl Med J. 2009 Jan 01;1:16-20. doi: 10.2174/1876399500901010016.

Common methods of statistical analysis, e.g. Analysis of Variance and Discriminant Analysis, are not necessarily optimal in selecting therapy for an individual patient. These methods rely on group differences to identify markers for disease or successful interventions and ignore...

Cite
Alemi F, Erdman H, Griva I, et al. Improved Statistical Methods are Needed to Advance Personalized Medicine. Open Transl Med J. 2009;1:16-20doi: 10.2174/1876399500901010016.
Alemi, F., Erdman, H., Griva, I., & Evans, C. H. (2009). Improved Statistical Methods are Needed to Advance Personalized Medicine. The open translational medicine journal, 116-20. https://doi.org/10.2174/1876399500901010016
Alemi, Farrokh, et al. "Improved Statistical Methods are Needed to Advance Personalized Medicine." The open translational medicine journal vol. 1 (2009): 16-20. doi: https://doi.org/10.2174/1876399500901010016
Alemi F, Erdman H, Griva I, Evans CH. Improved Statistical Methods are Needed to Advance Personalized Medicine. Open Transl Med J. 2009 Jan 01;1:16-20. doi: 10.2174/1876399500901010016. PMID: 20676226; PMCID: PMC2911789.
Copy Download .nbib Format: NLM
Percutaneous coronary interventions in Europe 1992-2003.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Cook S, Togni M, Walpoth N, Maier W, Muehlberger V, Legrand V, Milicic D, Zambartas C, Zelizko M, Madsen JK, van Buuren F, Lòpez-Palop R, Peeba M, Koskenkorva J, Vanhanen H, Lablanche JM, Lazaris I, Géza F, Eyjolfsson K, Kearney P, Piscione F, Erglis A, Navickas R, Beissel J, Channam R, Koch K, Deleanu D, Melberg T, Witkowski A, Pereira H, Reho I, Fridrich V, Zorman D, Nilsson T, Oezmen F, Ludman P, Meier B.
PMID: 19755208
EuroIntervention. 2006 Feb;1(4):374-9.

AIMS: The purpose of this registry is to collect data on trends in interventional cardiology within Europe. Special interest focuses on relative increases and ratios in newer revascularization approaches and its distribution in different regions in Europe. We report...

Cite
Cook S, Togni M, Walpoth N, et al. Percutaneous coronary interventions in Europe 1992-2003. EuroIntervention. 2006;1(4):374-9
Cook, S., Togni, M., Walpoth, N., Maier, W., Muehlberger, V., Legrand, V., Milicic, D., Zambartas, C., Zelizko, M., Madsen, J. K., van Buuren, F., Lòpez-Palop, R., Peeba, M., Koskenkorva, J., Vanhanen, H., Lablanche, J. M., Lazaris, I., Géza, F., Eyjolfsson, K., Kearney, P., Piscione, F., Erglis, A., Navickas, R., Beissel, J., Channam, R., Koch, K., Deleanu, D., Melberg, T., Witkowski, A., Pereira, H., Reho, I., Fridrich, V., Zorman, D., Nilsson, T., Oezmen, F., Ludman, P., & Meier, B. (2006). Percutaneous coronary interventions in Europe 1992-2003. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 1(4), 374-9.
Cook, Stéphane, et al. "Percutaneous coronary interventions in Europe 1992-2003." EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology vol. 1,4 (2006): 374-9.
Cook S, Togni M, Walpoth N, Maier W, Muehlberger V, Legrand V, Milicic D, Zambartas C, Zelizko M, Madsen JK, van Buuren F, Lòpez-Palop R, Peeba M, Koskenkorva J, Vanhanen H, Lablanche JM, Lazaris I, Géza F, Eyjolfsson K, Kearney P, Piscione F, Erglis A, Navickas R, Beissel J, Channam R, Koch K, Deleanu D, Melberg T, Witkowski A, Pereira H, Reho I, Fridrich V, Zorman D, Nilsson T, Oezmen F, Ludman P, Meier B. Percutaneous coronary interventions in Europe 1992-2003. EuroIntervention. 2006 Feb;1(4):374-9. PMID: 19755208.
Copy Download .nbib Format: NLM
Can abuse deterrent formulations make a difference? Expectation and speculation.

Harm reduction journal

Budman SH, Grimes Serrano JM, Butler SF.
PMID: 19480676
Harm Reduct J. 2009 May 29;6:8. doi: 10.1186/1477-7517-6-8.

It is critical that issues surrounding the abuse and misuse of prescription opioids be balanced with the need for these medications for the treatment of pain. One way to decrease the abuse of prescription opioid medications is to develop...

Cite
Budman SH, Grimes Serrano JM, Butler SF. Can abuse deterrent formulations make a difference? Expectation and speculation. Harm Reduct J. 2009;6:8doi: 10.1186/1477-7517-6-8.
Budman, S. H., Grimes Serrano, J. M., & Butler, S. F. (2009). Can abuse deterrent formulations make a difference? Expectation and speculation. Harm reduction journal, 68. https://doi.org/10.1186/1477-7517-6-8
Budman, Simon H, et al. "Can abuse deterrent formulations make a difference? Expectation and speculation." Harm reduction journal vol. 6 (2009): 8. doi: https://doi.org/10.1186/1477-7517-6-8
Budman SH, Grimes Serrano JM, Butler SF. Can abuse deterrent formulations make a difference? Expectation and speculation. Harm Reduct J. 2009 May 29;6:8. doi: 10.1186/1477-7517-6-8. PMID: 19480676; PMCID: PMC2694768.
Copy Download .nbib Format: NLM
Development and validation of an Opioid Attractiveness Scale: a novel measure of the attractiveness of opioid products to potential abusers.

Harm reduction journal

Butler SF, Benoit C, Budman SH, Fernandez KC, McCormick C, Venuti SW, Katz N.
PMID: 16457713
Harm Reduct J. 2006 Feb 02;3:5. doi: 10.1186/1477-7517-3-5.

BACKGROUND: The growing trends in opioid abuse, assessment of the abuse liability of prescription opioid products, and growing efforts by the pharmaceutical industry to develop 'abuse-resistant' formulations highlight a need to understand the features that make one product more...

Cite
Butler SF, Benoit C, Budman SH, et al. Development and validation of an Opioid Attractiveness Scale: a novel measure of the attractiveness of opioid products to potential abusers. Harm Reduct J. 2006;3:5doi: 10.1186/1477-7517-3-5.
Butler, S. F., Benoit, C., Budman, S. H., Fernandez, K. C., McCormick, C., Venuti, S. W., & Katz, N. (2006). Development and validation of an Opioid Attractiveness Scale: a novel measure of the attractiveness of opioid products to potential abusers. Harm reduction journal, 35. https://doi.org/10.1186/1477-7517-3-5
Butler, Stephen F, et al. "Development and validation of an Opioid Attractiveness Scale: a novel measure of the attractiveness of opioid products to potential abusers." Harm reduction journal vol. 3 (2006): 5. doi: https://doi.org/10.1186/1477-7517-3-5
Butler SF, Benoit C, Budman SH, Fernandez KC, McCormick C, Venuti SW, Katz N. Development and validation of an Opioid Attractiveness Scale: a novel measure of the attractiveness of opioid products to potential abusers. Harm Reduct J. 2006 Feb 02;3:5. doi: 10.1186/1477-7517-3-5. PMID: 16457713; PMCID: PMC1382206.
Copy Download .nbib Format: NLM
Involvement of prostate specific antigen in the stimulation of LNCaP cell growth.

Oncology reports

Wang L, Liu X, Kreis W, Budman D.
PMID: 21594481
Oncol Rep. 1996 Sep;3(5):911-7. doi: 10.3892/or.3.5.911.

Since its identification in 1979, prostatic specific antigen (PSA) has been used extensively as a serum marker for diagnosis and prognosis of prostate cancer. In addition, PSA is an immunohistochemical marker for the identification of prostatic tissues and cells...

Cite
Wang L, Liu X, Kreis W, et al. Involvement of prostate specific antigen in the stimulation of LNCaP cell growth. Oncol Rep. 1996;3(5):911-7doi: 10.3892/or.3.5.911.
Wang, L., Liu, X., Kreis, W., & Budman, D. (1996). Involvement of prostate specific antigen in the stimulation of LNCaP cell growth. Oncology reports, 3(5), 911-7. https://doi.org/10.3892/or.3.5.911
Wang, L, et al. "Involvement of prostate specific antigen in the stimulation of LNCaP cell growth." Oncology reports vol. 3,5 (1996): 911-7. doi: https://doi.org/10.3892/or.3.5.911
Wang L, Liu X, Kreis W, Budman D. Involvement of prostate specific antigen in the stimulation of LNCaP cell growth. Oncol Rep. 1996 Sep;3(5):911-7. doi: 10.3892/or.3.5.911. PMID: 21594481.
Copy Download .nbib Format: NLM
Quality-control analytical methods: endotoxins: essential testing for pyrogens in the compounding laboratory, part2.

International journal of pharmaceutical compounding

Cooper JF, Chakrabarty K, McGuire J, Zolner WJ, Jones V, Hedman H.
PMID: 23965654
Int J Pharm Compd. 2010 Nov-Dec;14(6):493-506.

Ensuring that the endotoxin burden in sterile preparations is within allowable limits is one of the greatest challenges faced by compounding pharmacists. Today, endotoxin analyses can be performed in the pharmacy with a test kit or accomplished by sending...

Cite
Cooper JF, Chakrabarty K, McGuire J, et al. Quality-control analytical methods: endotoxins: essential testing for pyrogens in the compounding laboratory, part2. Int J Pharm Compd. 2010;14(6):493-506
Cooper, J. F., Chakrabarty, K., McGuire, J., Zolner, W. J., Jones, V., & Hedman, H. (2010). Quality-control analytical methods: endotoxins: essential testing for pyrogens in the compounding laboratory, part2. International journal of pharmaceutical compounding, 14(6), 493-506.
Cooper, James F, et al. "Quality-control analytical methods: endotoxins: essential testing for pyrogens in the compounding laboratory, part2." International journal of pharmaceutical compounding vol. 14,6 (2010): 493-506.
Cooper JF, Chakrabarty K, McGuire J, Zolner WJ, Jones V, Hedman H. Quality-control analytical methods: endotoxins: essential testing for pyrogens in the compounding laboratory, part2. Int J Pharm Compd. 2010 Nov-Dec;14(6):493-506. PMID: 23965654.
Copy Download .nbib Format: NLM
Quality-control analytical methods: endtoxins: essential testing for pyrogens in the compounding laboratory, part 1.

International journal of pharmaceutical compounding

Dubczak J, Latta KS, Hedman H, Smith DR.
PMID: 23965585
Int J Pharm Compd. 2010 Sep-Oct;14(5):407-14.

Inadvertent exposure to endotoxins administered intravenously, intramuscularly, or intrathecally can cause a constellation of adverse effects that range from fever to multiple organ failure and death. Pharmacists who compound sterile formulations must remain exceptionally vigilant to guard against the...

Cite
Dubczak J, Latta KS, Hedman H, et al. Quality-control analytical methods: endtoxins: essential testing for pyrogens in the compounding laboratory, part 1. Int J Pharm Compd. 2010;14(5):407-14
Dubczak, J., Latta, K. S., Hedman, H., & Smith, D. R. (2010). Quality-control analytical methods: endtoxins: essential testing for pyrogens in the compounding laboratory, part 1. International journal of pharmaceutical compounding, 14(5), 407-14.
Dubczak, John, et al. "Quality-control analytical methods: endtoxins: essential testing for pyrogens in the compounding laboratory, part 1." International journal of pharmaceutical compounding vol. 14,5 (2010): 407-14.
Dubczak J, Latta KS, Hedman H, Smith DR. Quality-control analytical methods: endtoxins: essential testing for pyrogens in the compounding laboratory, part 1. Int J Pharm Compd. 2010 Sep-Oct;14(5):407-14. PMID: 23965585.
Copy Download .nbib Format: NLM
Early experience with medial femoral tension band plating in idiopathic genu valgum.

Journal of children's orthopaedics

Guzman H, Yaszay B, Scott VP, Bastrom TP, Mubarak SJ.
PMID: 21415941
J Child Orthop. 2011 Feb;5(1):11-7. doi: 10.1007/s11832-010-0310-6. Epub 2010 Dec 08.

PURPOSE: For correction of angular deformity, tension band plating has been proposed as a safe and minimally invasive technique. The purpose of this study was to assess the experiences and report the rate of correction obtained with this procedure...

Cite
Guzman H, Yaszay B, Scott VP, et al. Early experience with medial femoral tension band plating in idiopathic genu valgum. J Child Orthop. 2010;5(1):11-7doi: 10.1007/s11832-010-0310-6.
Guzman, H., Yaszay, B., Scott, V. P., Bastrom, T. P., & Mubarak, S. J. (2011). Early experience with medial femoral tension band plating in idiopathic genu valgum. Journal of children's orthopaedics, 5(1), 11-7. https://doi.org/10.1007/s11832-010-0310-6
Guzman, Humberto, et al. "Early experience with medial femoral tension band plating in idiopathic genu valgum." Journal of children's orthopaedics vol. 5,1 (2011): 11-7. doi: https://doi.org/10.1007/s11832-010-0310-6
Guzman H, Yaszay B, Scott VP, Bastrom TP, Mubarak SJ. Early experience with medial femoral tension band plating in idiopathic genu valgum. J Child Orthop. 2011 Feb;5(1):11-7. doi: 10.1007/s11832-010-0310-6. Epub 2010 Dec 08. PMID: 21415941; PMCID: PMC3024485.
Copy Download .nbib Format: NLM
Analysis of Flavonoid in Medicinal Plant Extract Using Infrared Spectroscopy and Chemometrics.

Journal of analytical methods in chemistry

Wulandari L, Retnaningtyas Y, Nuri, Lukman H.
PMID: 27529051
J Anal Methods Chem. 2016;2016:4696803. doi: 10.1155/2016/4696803. Epub 2016 Jul 26.

Infrared (IR) spectroscopy combined with chemometrics has been developed for simple analysis of flavonoid in the medicinal plant extract. Flavonoid was extracted from medicinal plant leaves by ultrasonication and maceration. IR spectra of selected medicinal plant extract were correlated...

Cite
Wulandari L, Retnaningtyas Y, Nuri, et al. Analysis of Flavonoid in Medicinal Plant Extract Using Infrared Spectroscopy and Chemometrics. J Anal Methods Chem. 2016;2016:4696803doi: 10.1155/2016/4696803.
Wulandari, L., Retnaningtyas, Y., Nuri, & Lukman, H. (2016). Analysis of Flavonoid in Medicinal Plant Extract Using Infrared Spectroscopy and Chemometrics. Journal of analytical methods in chemistry, 20164696803. https://doi.org/10.1155/2016/4696803
Wulandari, Lestyo, et al. "Analysis of Flavonoid in Medicinal Plant Extract Using Infrared Spectroscopy and Chemometrics." Journal of analytical methods in chemistry vol. 2016 (2016): 4696803. doi: https://doi.org/10.1155/2016/4696803
Wulandari L, Retnaningtyas Y, Nuri, Lukman H. Analysis of Flavonoid in Medicinal Plant Extract Using Infrared Spectroscopy and Chemometrics. J Anal Methods Chem. 2016;2016:4696803. doi: 10.1155/2016/4696803. Epub 2016 Jul 26. PMID: 27529051; PMCID: PMC4977382.
Copy Download .nbib Format: NLM
Resistance to vertical root fracture of root filled teeth using different conceptual approaches to canal preparation.

International endodontic journal

Prado M, de Lima NRB, de Lima CO, Gusman H, Simão RA.
PMID: 26334132
Int Endod J. 2016 Sep;49(9):898-904. doi: 10.1111/iej.12540. Epub 2015 Oct 03.

AIM: To evaluate the resistance to vertical root fracture of root filled teeth using different root canal preparation concepts: apical stop and continuously tapering preparation, with different foraminal enlargement. In addition, the effect of filling associated with these different...

Cite
Prado M, de Lima NRB, de Lima CO, et al. Resistance to vertical root fracture of root filled teeth using different conceptual approaches to canal preparation. Int Endod J. 2015;49(9):898-904doi: 10.1111/iej.12540.
Prado, M., de Lima, N. R. B., de Lima, C. O., Gusman, H., & Simão, R. A. (2016). Resistance to vertical root fracture of root filled teeth using different conceptual approaches to canal preparation. International endodontic journal, 49(9), 898-904. https://doi.org/10.1111/iej.12540
Prado, M, et al. "Resistance to vertical root fracture of root filled teeth using different conceptual approaches to canal preparation." International endodontic journal vol. 49,9 (2016): 898-904. doi: https://doi.org/10.1111/iej.12540
Prado M, de Lima NRB, de Lima CO, Gusman H, Simão RA. Resistance to vertical root fracture of root filled teeth using different conceptual approaches to canal preparation. Int Endod J. 2016 Sep;49(9):898-904. doi: 10.1111/iej.12540. Epub 2015 Oct 03. PMID: 26334132.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 109 entries